U.S. Industrials Stock News

The latest move in Baldwin Insurance Group (BWIN) stock was driven by its Q2 2026 earnings release and fresh Q3 revenue guidance, which together reshaped how investors view growth and profitability. See our latest analysis for Baldwin Insurance Group. Over the past year Baldwin Insurance Group has delivered a mixed picture for investors, with a strong 90 day share price return of 43.18% and year to date share price return of 23.97% contrasting with a 1 year total shareholder return that...

Inspire Medical Systems stock is coming off a sharp three year share price decline, yet the current valuation checks paint a more balanced picture. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares are roughly in line with fair value, and the earnings and revenue multiples lean toward undervalued. The share price has fallen 78.7% over the past three years, which puts a heavy focus on whether the current level fairly reflects Inspire Medical Systems' long term cash...

Regeneron Pharmaceuticals, Inc. previously reported second-quarter 2026 revenue of US$4,290.7 million versus US$3,675.6 million a year earlier, while net income eased to US$1,296.9 million from US$1,391.6 million and diluted earnings per share from continuing operations slipped to US$12.23 from US$12.81. At the same time, the company affirmed a quarterly dividend of US$0.94 per share payable on August 31, 2026, underscoring its willingness to return cash to shareholders even as earnings...

Lam Research stock has delivered a very strong 402.9% return over the past five years, yet its current checks lean toward the shares looking expensive rather than like an obvious bargain. After a sharp recent move, investors are weighing that long run against signals that the valuation may be demanding. A roughly fivefold gain over five years suggests Lam Research has already priced in a lot of optimism about its role in the semiconductor cycle and AI related demand. Recent enthusiasm around...

Dover stock has already returned 47.9% over the past three years, and the latest intrinsic value work using a Discounted Cash Flow (DCF) approach still points to the shares trading at a discount to that estimate rather than at a clear premium. A 47.9% gain over three years suggests Dover has rewarded patient shareholders while still leaving the question of further upside open. The planned acquisition of Cloeren can support expectations for future cash flows, while the usual integration and...

Custom Truck One Source, Inc. reported past second-quarter 2026 results showing sales of US$145.06 million and revenue of US$563.45 million, with net income of US$10.4 million and basic earnings per share from continuing operations of US$0.05, compared with a loss a year earlier. Importantly, the company also returned to profitability for the first half of 2026 and raised full-year revenue guidance to between US$2.10 billion and US$2.20 billion, indicating management’s increased confidence...

Verisk Analytics (NasdaqGS:VRSK) has announced that long-serving EVP and CIO Nick Daffan is stepping down after more than two decades with the company. The company’s CTO will assume interim CIO responsibilities as Verisk continues to focus on advanced analytics, cloud infrastructure and AI-related initiatives. Verisk Analytics operates as a data and analytics provider with a strong focus on insurance and risk-related solutions. The company has invested heavily in cloud migration and digital...

Markets are trying to make sense of Fed Chair Kevin Warsh’s new hands off stance on inflation, with long term yields at 19 year highs and volatility back in focus. When policy guidance feels uncertain, large banking and financial services stocks can either absorb the shock or feel it more sharply, depending on how their funding, lending and trading books respond to higher yields and shifting risk appetite. This article looks at three financially solid stocks from our screener that appear...

Roku (ROKU) is drawing fresh attention as Wall Street analysts look ahead to its upcoming quarterly report, with expectations focused on stronger earnings, higher revenue, and mixed trends across its platform and device businesses. See our latest analysis for Roku. Roku's share price has climbed over the past year, with a 90 day share price return of 13.96% and year to date share price return of 34.14%. At the same time, the 1 year total shareholder return of 74.37% contrasts with a 5 year...

Anterix (ATEX) has drawn fresh attention after recent trading left the stock around $95.65, with short term moves contrasting with a stronger performance over the past 3 months and year to date. See our latest analysis for Anterix. Recent price action in Anterix points to strong momentum, with a 1 day share price return of 2.83% and a 7 day gain of 4.68%, set against a softer 30 day share price return showing a 9.03% decline. Even so, the 90 day share price return of 84.23%, year to date gain...

QCR Holdings (QCRH) has drawn fresh attention after reporting second quarter 2026 results that showed higher net interest income and net income year over year, along with declining net charge offs as the m2 portfolio winds down. See our latest analysis for QCR Holdings. At a share price of $104.40, QCR Holdings has seen momentum build, with a 30 day share price return of 8.02% and a year to date share price return of 27.10%, while the 1 year total shareholder return of 47.47% sits within a...

AbbVie (ABBV) lifted its full year 2026 revenue guidance to about US$67.6b, adding US$300m to its outlook, while also issuing third quarter revenue guidance and reporting detailed second quarter results. See our latest analysis for AbbVie. Despite AbbVie lifting its 2026 revenue outlook and reporting higher second quarter sales and net income, the stock has recently cooled, with the 7 day share price return down 6.88% and the 30 day share price return down 6.12%. That comes after a stronger...

A calmer backdrop after the called off U.S. strikes on Iran, softer oil prices, and renewed confidence in megacap technology have helped improve sentiment around US blue chip dividend stocks. For income focused investors, that mix can make dependable payers with strong balance sheets look more interesting, especially as the S&P 500 recently recovered from a technology led selloff. This article looks at how those catalysts relate to three individual dividend stocks in the screener and why...

Tariffs are back in the headlines, with 25 states challenging the Trump administration’s latest round that touches nearly all U.S. imports from 59 countries and the EU. For U.S. Domestic Manufacturing Stocks, this legal and trade backdrop can change the balance between import heavy companies and those with a stronger local production base. Higher costs and supply chain friction may hurt some businesses and create openings for others. This article breaks down how that trade shock could matter...

Entravision Communications (EVC) has drawn investor attention after recent trading, with the stock down about 15% over the past month yet up roughly 44% in the past 3 months. See our latest analysis for Entravision Communications. Zooming out, Entravision Communications has seen short term momentum cool, with a 1 month share price return of about a 15% decline, while a very strong 1 year total shareholder return of around 413% points to powerful longer term gains. If you are looking for other...

Alexandria Real Estate Equities, Inc. reported second-quarter 2026 revenue of US$662.78 million with a US$72.78 million net loss, while its six-month results showed revenue of US$1,333.81 million and net income of US$288.87 million, alongside progress on the MAP-D depression research initiative with the Foundation for the National Institutes of Health. The MAP-D collaboration, now through its critical design phase and moving toward a research effort expected to exceed US$70 million,...

BioNTech SE has reported past second-quarter 2026 results showing sales of €105.6 million versus €260.8 million a year earlier, with net loss widening to €820.8 million and basic loss per share from continuing operations increasing to €3.24 from €1.60. At the same time, the Supervisory Board has moved to refresh leadership by appointing experienced biopharma executive Guido Oelkers as future CEO, a shift that could influence how BioNTech balances heavy R&D spending with efforts to broaden...

Opera (NasdaqGS:OPRA) is back in focus after reporting 288 million monthly active users in the first quarter of 2026, a 25% rise in annualized average revenue per user, and approving a $300 million share repurchase program. See our latest analysis for Opera. At a share price of US$19.51, Opera has seen a 37.10% year to date share price return and a 26.35% total shareholder return over the past year. Multi year total shareholder returns above 100% suggest longer term holders have already...

Workiva (WK) has just rolled out three AI agents and a new Workiva Knowledge layer that aim to cut manual work in financial reporting, compliance, and sustainability disclosures for enterprise customers. See our latest analysis for Workiva. The new AI agents arrive at a time when Workiva’s recent 30-day share price return of 17.85% and 90-day share price return of 18.77% contrast with a year-to-date share price decline of 26.24% and a 3-year total shareholder return decline of 42.69%. This...

TransMedics Group, Inc. recently announced it will report its Q2 2026 financial results and host an earnings call after the market closes on August 4, 2026, while also granting stock options and restricted stock units to new employees under Nasdaq Listing Rule 5635(c)(4). Together with fresh UBS research coverage, these developments highlight how external analyst attention and internal talent incentives are shaping investor focus on TransMedics’ next phase of growth. With new UBS coverage...

In recent months, ATI, ranked #2 (Buy) by Zacks in the aerospace sector, has seen analysts lift their full‑year earnings estimates by 2.3%, reflecting stronger sentiment toward its earnings outlook. This upgrade in expectations, alongside ATI’s year‑to‑date return of 63.3% that exceeds sector and industry averages, underscores how rapidly investor confidence has consolidated around the company’s role in aerospace materials. We’ll now examine how this upward shift in earnings expectations may...

AppFolio (APPF) is back in focus after its latest quarterly update, which combined second quarter 2026 earnings, fresh full year revenue guidance, and an update on its completed share repurchase program. See our latest analysis for AppFolio. The upbeat quarterly release and higher full year revenue outlook have come alongside a sharp rebound in sentiment, with a 14.67% 90 day share price return and 12.16% 30 day share price return. However, the total shareholder return is still down 38.89%...

Danaos Corporation has reported past second-quarter 2026 results showing sales of US$274.37 million and net income of US$151.82 million, with both basic and diluted earnings per share from continuing operations higher than a year earlier. The combination of rising sales and expanding earnings for both the quarter and first half of 2026 underscores resilient operating performance and margin strength in Danaos’s shipping portfolio. Next, we’ll examine how this earnings outperformance,...

Myers Industries (MYE) stock is in focus after the company reported second quarter 2026 results, with higher sales, net income and earnings per share compared with the same period a year earlier. See our latest analysis for Myers Industries. The strong quarterly update and the amended loan agreement appear to have fed into a sharp repricing of Myers Industries, with a 90 day share price return of 77.32% and a 1 year total shareholder return of 138.19% that indicates momentum building rather...